Psoriasis and Emerging Research Around Cannabinoids
Psoriasis is a long term inflammatory skin condition that can be challenging to manage. For many people, symptoms fluctuate over time and may flare in response to factors such as stress, illness, or environmental triggers. While a range of treatments are available, not everyone experiences the same level of benefit and some patients continue to look for additional ways to manage symptoms.
In recent years there has been increasing interest in the potential role of cannabinoids in skin health. Research in this area is still developing, but it has prompted discussion about how these compounds interact with the body’s regulatory systems.
Understanding Psoriasis
Psoriasis is an autoimmune condition in which the immune system accelerates the production of skin cells. This can lead to patches of dry, inflamed, and scaly skin.
The condition most commonly appears on areas such as the elbows, knees, scalp, and lower back, although it can occur anywhere on the body.
Some key points about psoriasis include:
• Symptoms can vary widely in severity
• Flare ups may be triggered by factors such as stress, infection, or skin injury
Because psoriasis is influenced by multiple biological and environmental factors, management often involves a combination of approaches over time.
Interest in Cannabinoids and Skin Health
The cannabis plant contains a number of naturally occurring compounds known as cannabinoids. Two of the most widely studied are cannabidiol (CBD) and tetrahydrocannabinol (THC).
Research has explored how cannabinoids interact with the body’s endocannabinoid system, which plays a role in regulating processes such as immune activity, inflammation, and skin function.
Early laboratory studies have suggested that cannabinoids may influence inflammatory pathways and skin cell behaviour. However, clinical research in humans remains limited and further study is needed to understand how these findings may translate into medical treatment.
Current Treatment Approaches
Psoriasis is usually managed through established treatments such as topical therapies, phototherapy, and systemic medications. These approaches aim to reduce inflammation, manage symptoms, and limit flare ups.
For patients whose symptoms affect sleep, pain levels, or overall wellbeing, clinicians may sometimes explore additional supportive approaches depending on the individual situation.
Clinical Assessment
Cannabis based medicines in the UK can only be prescribed by specialist clinicians and are generally considered when other treatment options have not provided sufficient benefit.
Specialist clinics such as Keltoi Clinic provide consultations where clinicians review medical history, discuss symptoms, and assess whether cannabis based treatment may be appropriate for a patient’s individual circumstances.
Because psoriasis affects people in different ways, any treatment decision requires careful clinical assessment and ongoing monitoring.
Conclusion
Psoriasis is a complex condition that often requires long term management and a personalised approach to care. While research into cannabinoids and skin health is continuing, patients should discuss all treatment options with a qualified healthcare professional.
Understanding the available therapies and the evolving evidence base can help patients make informed decisions about their care.
Information provided for general guidance only. Individual suitability is assessed by a clinician.